Company Valuation: CARE Ratings Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028 2029
Market Cap 1 15,133 19,092 33,416 33,105 43,523 50,131 - -
Change - 26.16% 75.03% -0.93% 31.47% 15.18% - -
Enterprise Value (EV) 15,133 19,092 33,416 33,105 43,523 50,131 50,131 50,131
Change - 26.16% 75.03% -0.93% 31.47% 15.18% 0% 0%
P/E 20.2x 22.8x 33.2x 24.2x 25.5x 24.6x 21.3x 18.6x
PBR 2.34x 2.67x 4.61x 4.07x 4.68x 4.64x 4.05x 3.53x
PEG - 2x 1.7x 0.7x 1x 1.3x 1.4x 1.3x
Capitalization / Revenue 6.11x 6.68x 10.1x 8.23x 9.2x 9.06x 7.86x 6.89x
EV / Revenue 0x 0x 0x 0x 0x 9.06x 7.86x 6.89x
EV / EBITDA 0x 0x 0x 0x 0x 21.7x 18.6x 16.2x
EV / EBIT 0x 0x 0x 0x 0x 23.4x 20x 17.4x
EV / FCF 0x 0x 0x 0x 0x 22.3x 19.4x 16.9x
FCF Yield 3.24% 3.71% 2.45% 3.27% 3.2% 4.49% 5.15% 5.9%
Dividend per Share 2 17 17 17 18 14 26.1 28.7 32.7
Rate of return 3.33% 2.64% 1.52% 1.63% 0.97% 1.56% 1.72% 1.96%
EPS 2 25.31 28.17 33.67 45.69 56.83 67.7 78.2 89.8
Distribution rate 67.2% 60.3% 50.5% 39.4% 24.6% 38.6% 36.7% 36.4%
Net sales 1 2,476 2,859 3,317 4,023 4,731 5,535 6,375 7,276
EBITDA 1 798.2 993.4 1,121 1,553 1,974 2,306 2,701 3,102
EBIT 1 721.2 945.2 1,017 1,436 1,830 2,142 2,510 2,877
Net income 1 751.1 835.3 1,005 1,372 1,712 2,032 2,347 2,695
Net Debt - - - - - - - -
Reference price 2 510.45 642.80 1,119.40 1,106.00 1,448.50 1,668.30 1,668.30 1,668.30
Nbr of stocks (in thousands) 29,647 29,701 29,852 29,932 30,047 30,049 - -
Announcement Date 5/29/22 5/11/23 5/9/24 5/12/25 5/13/26 - - -
1INR in Million2INR
Estimates

P/E, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
24.64x - - 1.56% 527M
31.24x11.04x21.04x0.86% 85.68B
31.55x - - 1.9% 3.14B
27.43x - - 1.48% 538M
Average 28.72x 11.04x 21.04x 1.45% 22.47B
Weighted average by Cap. 31.19x 11.04x 21.04x 0.9%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. CARERATING Stock
  4. Valuation CARE Ratings Limited